Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Tarif impor AS ke Indonesia: seberapa berdampak terhadap pertumbuhan ekonomi nasional?

Presiden Amerika Serikat, Donald Trump, mengumumkan penyesuaian kebijakan tarif impor baru bagi Indonesia menjadi 19%. Hal ini diklaim buah hasil negosiasi perdagangan antara kedua negara yang memberi...

Cara membuat prompt AI yang bagus biar produktif: tip dari ahli

FOTOSPLASH/Shutterstock“Apakah kamu mampu memanfaatkan AI dalam pekerjaan?”Kecerdasan buatan alias artificial intelligence (AI) sudah jadi bagian dari keseharian kita. Mulai dari ChatGPT, ...

Cara membahas masalah tanpa menimbulkan pertengkaran: Tip dari ahli

Pormezz / ShutterstockKita sebagai manusia memiliki perbedaan satu sama lain yang memengaruhi pendapat kita. Maka dari itu, ada kalanya kita tidak setuju dengan pendapat orang lain.Berbeda pendapat ka...